[Clinical application of new synthetic vasopressin 1-deamino-8-D-arginine vasopressin (DDAVP): hemostatic control of von Willebrand's disease (author's transl)].
D000293:Adolescent; D000328:Adult; D001127:Arginine Vasopressin / Q000627:therapeutic use*; D003894:Deamino Arginine Vasopressin / Q000627:therapeutic use*; D005176:Factor XIII / Q000032:analysis; D005260:Female; D006487:Hemostasis / Q000187:drug effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D013997:Time Factors; D014842:von Willebrand Diseases / Q000097:blood / Q000188:drug therapy*
D001127:Arginine Vasopressin; D005176:Factor XIII; D003894:Deamino Arginine Vasopressin